NeuroSense Therapeutics Ltd.

NRSNNASDAQ Capital Market·USD·Closed

NRSNNASDAQ·USD·Closed

$0.47

−2.27%

$0.47

−$0.01 (2.27%)

52W Range

2thpctl

Volume

0.51×avg

Mkt Cap

16.44MUSD

P/E

-1.0TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

2thpctl

Volume

0.51×avg

Market Cap

16.44MUSD

P/E Ratio

-1.0TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Mixed

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC797.5%

Financially safe

Stretched

Debt / equity-0.11×

Interest coverage-652.1×

Current ratio0.31×